CYP24A1 and hypercalcemia, infantile: These patients presented with phenotypic and laboratory characteristics that were originally reported as idiopathic infantile hypercalcemia (IIH) (15–17), since the first described cohort of patients with CYP24A1 mutations in the 1950s.